Parkinson’s Disease Course for SLPs
Let's Talk About Parkinson's: How can Speech and Language Pathologists Deliver the Best Care? #313279
WHEN: SAT 28 OCT 2017
TIME: 8:00 AM – 5:00 PM (lunch included)
Created by the Parkinson’s Foundation, this day-long educational program is being designed for Speech and Language Pathologists (SLPs) who deliver care to those living with Parkinson’s throughout the spectrum of the disease. Parkinson's disease affects not only speech, voice and swallowing, but also the gestures and facial expressions that are critical to communication. We’re looking to further educate SLPs to examine the complexities that Parkinson’s has on vocalization and swallow behaviors and explore how anti-Parkinson medications influence complex sensorimotor enrichment outcomes. This program will be recorded for webcasting.
For incredible value, this course is included in the WORLD PASS
While this course is included in the WORLD PASS, unlike other courses lunch is included, therefore this course has a separate pricing structure when purchased a la carte — please see bottom of this page. Advance registration is required. This course will likely sell out.
WHO SHOULD ATTEND?
Speech Language Pathologists
All-day live instruction, lunch, CME / CEUs. Non-member registration includes a 6-month introductory membership to ACRM.
Register early — save the most! Register now
Jessica E. Huber, MA, PhD, CCC-SLP
Professor, Purdue University
Leslie Mahler, PhD, CCC-SLP
Associate Professor, University of Rhode Island
Michelle R. Ciucci, PhD, CCC-SLP
Associate Professor, University of Wisconsin
Karen Hegland, PhD, CCC-SLP
Assistant Professor, University of Florida
Nina Browner, MD
Associate Professor, University of North Carolina at Chapel Hill
Lori Campbell, MA, CCC-SLP
Citrus Valley Healthcare Partners
Jessica E. Huber, PhD, CCC-SLP, is a Professor of Speech, Language, and Hearing Sciences at Purdue University. The aim of Dr. Huber’s research program is to develop a theoretical account of the multiple factors that influence speech production and cognitive change in individuals with Parkinson’s disease (PD) and to translate findings to clinical treatment resulting in improvements in communication. Dr. Huber’s research is funded by the National Institutes of Health. She is the inventor of a small wearable device, the SpeechVive device, to treat communication impairments in people with PD. The device elicits the Lombard effect that can be exploited to improve speech clarity in individuals with PD while bypassing cognitive and sensory impairments. Her current research continues to examine the effects a number of speech therapy techniques including respiratory muscle strength training and using the SpeechVive device, and collaborating to develop a new balance-training paradigm.
Dr. Leslie Mahler has over 30 years of clinical experience working primarily with adults with neurological disorders prior to joining the faculty at URI. Dr. Mahler is actively involved in clinical research at URI investigating the efficacy of voice, speech and swallow treatment in Parkinson’s disease, stroke and Down syndrome and has made numerous presentations at national and international conferences. She is a certified clinician in the LSVT(R) LOUD, an efficacious treatment approach for improving voice and speech function for people with Parkinson disease. She is also the principal investigator on a multidisciplinary research project with Nutrition and Food Science and Kinesiology examining longitudinal changes in people with chronic neurological diagnoses such as acquired brain injury, stroke and Parkinson disease.
Michelle R. Ciucci, PhD, CCC-SLP is an Associate Professor in the Departments of Communication Sciences and Disorders and Surgery-Otolaryngology Head and Neck Surgery and faculty in the Neuroscience Training Program at the University of Wisconsin-Madison. Her translational research program is directed at improving treatments for voice and swallowing disorders. She works with animal models as well as human clinical populations. Dr. Ciucci’s larger research framework studies the relevant neurobiological processes that affect disease progression and how targeted exercise may slow or reverse the degenerative processes. Understanding these mechanisms will lead to better treatments and functional outcomes for patients with Parkinson Disease and other neurologic disease, including drug discovery and repurposing and behavioral interventions. Dr. Ciucci has authored over 45 peer-reviewed published scientific journal articles, 8 book chapters, and has given numerous national and international talks on her research and clinical experience. She has been funded by the National Institutes of Health (F32, R01, P30, T32) and the Michael J. Fox Foundation for Parkinson’s research.
Dr. Karen Hegland’s research interests focus on mechanisms of normal and disordered airway protection. These mechanisms include sensorimotor aspects of swallowing and cough. The primary research methods employed by her laboratory include reflex cough testing, aerodynamic cough analysis, videoflurorscopic swallow evaluation, laryngoscopy, and respiratory load magnitude estimation. Current research protocols seek to enroll participants with neurodegenerative disease, such as Parkinson’s disease, patients who have had a stroke, patients with certain voice disorders, and healthy older adults.
Dr. Nina Browner is an Associate Professor of Neurology at the University of North Carolina and Director of the Parkinson Foundation Center of Excellence at University of North Carolina. After graduating from the Moscow Medical Academy in Russia, she received the prestigious Research Presidential Scholarship of the Russian Federation and spent two years at Johns Hopkins University doing research in functional MRI in Parkinson’s disease. She then continued her training with Neurology Residency at the Cleveland Clinic Foundations and a fellowship in Movement Disorders with Dr. Stanley Fahn at the Columbia University Medical Center. Her research interests include gait abnormalities in patients with Parkinson’s disease and cognitive changes on different stages of Parkinson’s disease. In addition to her dual roles of clinician and researcher, Dr. Browner mentors medical students and neurology residents as Neurology Residency Program director and had been awarded Collin Hall Award in Teaching Excellence from the Department of Neurology at the University of North Carolina, Chapel Hill.
Lori Campbell, MA, CCC-SLP holds a degree from Berklee College of Music and began her career singing jingles for television and radio. Her experience as a vocalist and voice teacher sparked her interest in Speech-Language Pathology. She earned her Master’s Degree in Speech Language Pathology at California State University Los Angeles with a special interest in voice disorders. She received Allied Team Training for Parkinson’s sponsored by NPF in 2013, which helped her earn recognition as a clinical specialist in Neurophysiology and Neurogenic Speech and Language disorders by Citrus Valley Health Partners/East San Gabriel Valley Hospitals. She promotes health and wellness through creativity and shares her projects and journey living with Parkinson’s through her website and YouTube channels. WPC2016 Video Competition awarded her short film, VICTORY, Grand Prize at the Portland Congress.
- Describe how Parkinson’s impacts cognition, speech, swallowing and communication for people living with the disease and their care partners
- Evaluate how medications and deep-brain stimulation surgery affects cognition, speech and swallowing
- Illustrate how dysphagia, cognition and speech impairments impact health and quality of life issues
- Identify several treatment options available to people with Parkinson’s that have dysphagia, cognition and speech impairments
BODY OF ABSTRACT
Designed by the Parkinson’s Foundation and nationally acclaimed experts in speech and language in neurodegenerative diseases, we are creating an unique educational program designed for both an in person audience followed by an online webcast entitled, "Let’s talk About Parkinson’s: How can Speech and Language Pathologists Deliver the Best Care?"
Parkinson’s disease (PD), a common and debilitating neurodegenerative disorder, which causes problems with movement, balance and motor control, affects over 4.1 million people worldwide. The disease usually develops after age 60, although up to 15 percent of Parkinson’s patients are diagnosed before age 50. About 89% of people with Parkinson’s are affected by speech disorders. Estimates show that the number of people living with Parkinson’s will almost double by 2030. This increase means many things for the health care systems around the world, but specifically for speech therapists since they will be more exposed to people with PD.
This course is being designed to meet a demonstrated need for a better understanding of Parkinson’s among Speech and Language Pathologists who deliver care for those living with Parkinson’s throughout the spectrum of the disease.
PD affects not only speech, voice and swallowing, but also the gestures and facial expressions that are critical to communication. We’re looking to further educate SLPs to examine the complexities that Parkinson’s has on vocalization and swallow behaviors and explore how anti-Parkinson medications influence complex sensorimotor enrichment outcomes.
Primary Content Topic: Arts & Neuroscience
Secondary Content Topic: Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)
Key Words: Speech, Dysphagia, cognition, Parkinson's Disease, Language
$299 - $599 (from BEST MEMBER Rate to non-member onsite rate). Full pricing grid below.
BEST value is the WORLD PASS -- get all 6 days & CME / CEUs & More >>
through 22 OCT